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Abstract: The hedgehog signal pathway is an essential agent in developmental patterning, 
wherein  the  local  concentration  of  the  Hedgehog  morphogens  directs  cellular 
differentiation and expansion. Furthermore, the Hedgehog pathway has been implicated in 
tumor/stromal interaction and cancer stem cell. Nowadays searching novel inhibitors for 
Hedgehog Signal Pathway is drawing much more attention by biological, chemical and 
pharmological  scientists.  In  our  study,  a  solid computational  model  is  proposed which 
incorporates  various  statistical  analysis  methods  to  perform  a  Quantitative  
Structure-Activity Relationship (QSAR) study on the inhibitors of Hedgehog signaling. 
The  whole  QSAR  data  contain  93  cyclopamine  derivatives  as  well  as  their  activities 
against  four  different  cell  lines  (NCI-H446,  BxPC-3,  SW1990  and  NCI-H157).  Our 
extensive  testing  indicated  that  the  binary  classification  model  is  a  better  choice  for 
building  the  QSAR  model  of  inhibitors  of  Hedgehog  signaling  compared  with  other 
statistical methods and the corresponding in silico analysis provides three possible ways to 
improve  the  activity  of  inhibitors  by  demethylation,  methylation  and  hydroxylation  at 
specific positions of the compound scaffold respectively. From these, demethylation is the 
best  choice  for  inhibitor  structure  modifications.  Our  investigation  also  revealed  that  
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NCI-H466 served as the best cell line for testing the activities of inhibitors of Hedgehog 
signal pathway among others. 
Keywords: QSAR; Hedgehog signal pathway; inhibitor; cyclopamine 
 
Abbreviations 
R2 = correlation coefficient in self fitting of training data set 
Q2 = correlation coefficient in cross validation fitting of training data set 
r2 = correlation coefficient in fitting of test data set 
A = percentage accuracy of binary model = Total accuracy 
A0 = percentage accuracy of inactive subset 
A1 = percentage accuracy of active subset 
At = A in self fitting of training data set 
Av = A in cross validation fitting of training data set 
Ap = A in fitting of test data set 
DLI = Drug-like Index 
PLS = Partial Least Squares 
SVR = Support Vector Regression  
SVM = Support Vector Machine 
ANN = Artificial Neural Networks  
SAReport = Structure-Activity Report 
1. Introduction 
The hedgehog signaling pathway plays a key role in the control of cell differentiation, growth, and 
proliferation  [1].  Briefly,  hedgehog  signal  pathway  is  composed  of  four  important  components 
including Sonic Hedgehog, Patched, Smoothened and Gli transcription factors. Sonic Hedgehog is a 
secreted protein that can transduce signals between cells. Patched acts as a receptor protein to be 
binded  by  Sonic  Hedgehog.  When  Sonic  Hedgehog  is  absent,  Patched  can  block  the  function  of 
Smoothened. In addition, Smoothened would be activated and initiate a signaling cascade that results 
in the activation of Gli transcription factors when Sonic Hedgehog binds with Patched. These Gli 
transcription  factors  will  translocate  into  the  nucleus  where  the  transcription  of  target  genes  is 
controlled. Recent studies have found that constitutively activating the pathway can trigger cancer in 
adult  humans,  leading  to  basal  cell  carcinoma,  medulloblastoma,  rhabdomyosarcoma,  prostate, 
pancreatic and breast cancers [2–5]. 
Due  to  the  direct  relationship  between  the  activation  of  hedgehog  signaling  pathway  and 
oncogenesis, cancer researchers have been dedicated to find specific inhibitors of hedgehog signaling 
since  it  will  provide  efficient  therapies  for  a  wide  range  of  malignancies  [6–8].  Until  now,  only 
specific Smoothened inhibitors have been identified. Cyclopamine, a steroid alkaloid isolated from the 
corn lily (Veratrum californicum), is one of the small chemical compounds that specifically inhibit Int. J. Mol. Sci. 2011, 12                       
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Smoothened in the hedgehog signaling pathway [9]. However, there is still no efficient pathway to 
synthesis Cyclopamine because of its low solubility in aqueous or polar solvents and little effort has 
been devoted into the synthesis of cyclopamine derivatives [10–13]. In order to develop clinically 
effective  drugs,  modifications  of  parent  lead  compounds  to  generate  derivatives  to  study  the  
structure-activity  relationship  (SAR)  become  necessary  [13].  Janardanannair  et  al.  [9,14]  have 
pioneered  such  investigations  on the  SAR  of  cyclopamine  derivatives.  Their  results  quantitatively 
indicated that modification on secondary amine and oxidation to ketone from 3-Hydroxy could help to 
influence the activities of cyclopamine derivatives. However, both studies had less than 30 samples, 
which is far from satisfactory for a sound QSAR study.  
In order to better understand Hedgehog signal pathway as well as design efficient inhibitors for this 
pathway, 93 cyclopamine derivatives were synthesized and their activities were tested against four 
different cell lines (BxPC-3, NCI-H446, SW1990 and NCI-H157) respectively [15,16]. Based on these 
experimental data, a systematical investigation was carried out on SAR of inhibitors of Hedgehog 
signal pathway by incorporation of various statistic modeling approaches and comparison of different 
descriptors and statistical division approaches of these data. 
2. Results and Discussion 
Based on the computational framework outlined in Material and Methods, the following results or 
clues were obtained for the QSAR modeling of inhibitors of Hedgehog signal pathway.  
2.1. The Influence of Descriptors on the QSAR Modeling of Inhibitors of Hedgehog Signal Pathway 
As  mentioned  above,  two  distinct  sets  of  descriptors  were  tested  to  describe  the  93  chemical 
compounds respectively (Table 1 and Table 2). For the self-fitting of training data (highlighted in red), 
we found that the models derived from physical properties are more efficient than those derived from 
topological indices for QSAR modeling. It can be seen that almost all the values of σ in this case are 
negative. However, with regard to independent testing (highlighted in royal blue), it seems that QSAR 
models derived from the DLI descriptors [17] are much more robust than those derived from general 
descriptors [18], and in this case almost all the values σ are positive. As an intermediate state, the 
values of σ derived from cross validation (highlighted in yellow-green) contain several negative and 
positive ones respectively. In total, the above mentioned result indicated that when projecting the 
connection table information into physical properties, the general descriptors will lose some structural 
information of a compound. Such loss of information is different for training and testing datasets since 
this information is highly dependent on the conformation and structural essence of a molecule. 
In conclusion, models derived from DLI are much more stable for both training data and testing 
data, while general descriptors cannot guarantee such stability and scale in independent data. 
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Table 1. QSAR results derived from the data divided by Diverse Subset (σ indicates difference). 
  BxPC-3  NCI-H446  SW1990  NCI-H157 
General  Drug-like  σ  General  Drug-like  σ  General  Drug-like  σ  General  Drug-like  σ 
PLS  R2  0.552  0.494  −0.058  0.659  0.526  −0.133  0.644  0.585  −0.059  0.527  0.531  0.004 
Q2  0.000  0.035  0.035  0.001  0.026  0.025  0.021  0.158  0.137  0.038  0.106  0.068 
r2  0.102  0.307  0.205  0.218  0.025  −0.193  0.084  0.193  0.109  0.019  0.118  0.099 
SVR  R2  0.994  0.686  0.308  0.966  0.763  -0.203  0.993  0.808  −0.185  0.988  0.705  −0.283 
Q2  0.994  0.000  −0.994  0.962  0.002  −0.96  0.992  0.069  −0.923  0.987  0.001  −0.986 
r2  0.000  0.396  0.396  0.088  0.110  0.022  0.025  0.258  0.233  0.023  0.077  0.054 
Bayesian 
inference 
At  0.883  0.917  0.034  1.000  0.967  −0.033  0.900  0.933  0.033  0.967  0.933  −0.034 
Av  0.783  0.817  0.034  0.917  0.917  0  0.883  0.783  −0.1  0.867  0.867  0 
Ap  0.606  0.576  −0.03  0.758  0.879  0.121  0.576  0.667  0.091  0.485  0.636  0.151 
SVM
 
classification 
At  1.000  1.000  0  1.000  1.000  0  1.000  1.000  0  1.000  1.000  0 
Av  0.550  0.500  −0.05  0.867  0.817  −0.05  0.650  0.533  −0.117  0.633  0.617  −0.016 
Ap  0.455  0.636  0.181  0.788  0.879  0.091  0.545  0.758  0.213  0.697  0.636  −0.061 
Table 2. QSAR results derived from the data divided by Cluster plus Diverse Subset (σ indicates difference). 
  BxPC-3  NCI-H446  SW1990  NCI-H157 
General  Drug-like  σ  General  Drug-like  σ  General  Drug-like  σ  General  Drug-like  σ 
PLS  R2  0.506  0.474  −0.032  0.593  0.396  −0.197  0.542  0.493  −0.049  0.587  0.542  −0.045 
Q2  0.011  0.007  −0.004  0.015  0.019  0.004  0.005  0.002  −0.003  0.006  0.040  0.034 
r2  0.178  0.215  0.037  0.055  0.201  0.146  0.000  0.222  0.222  0.087  0.056  −0.031 
SVR  R2  0.997  0.716  −0.281  0.965  0.756  −0.209  0.993  0.839  −0.154  0.987  0.655  −0.332 
Q2  0.997  0.021  −0.976  0.962  0.025  −0.937  0.993  0.124  −0.869  0.986  0.019  −0.967 
r2  0.008  0.139  0.131  0.029  0.001  −0.028  0.040  0.075  0.035  0.019  0.087  0.068 
Bayesian 
inference 
At  0.967  0.885  −0.082  0.951  0.934  −0.017  0.934  0.918  −0.016  0.984  0.885  −0.099 
Av  0.852  0.803  −0.049  0.934  0.918  −0.016  0.852  0.836  −0.016  0.820  0.820  0 
Ap  0.656  0.625  −0.031  0.625  0.906  0.281  0.625  0.656  0.031  0.625  0.625  0 
SVM
 
classification 
At  1.000  0.984  −0.016  1.000  1.000  0  1.000  1.000  0  1.000  0.984  −0.016 
Av  0.505  0.475  −0.03  0.803  0.852  0.049  0.590  0.623  0.033  0.656  0.623  −0.033 
Ap  0.656  0.719  0.063  0.875  0.875  0  0.625  0.719  0.094  0.688  0.719  0.031 Int. J. Mol. Sci. 2011, 12                       
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2.2. The Influence of Data Division on the QSAR Modeling of Inhibitors of Hedgehog Signal Pathway  
It is normally known that QSAR predictions are only reliable within or near the property space used 
to train the model. Preparing a robust, unbiased and sufficiently large training set is critically important 
for the building of a proper statistical model. As mentioned above, two data division methods, i.e., 
Diverse Subset and Cluster plus Diverse Set were applied to divide our dataset into training set and 
testing set. 
In order to statistically reveal the difference between the results influenced by two such kinds of 
data divisions, pair t-test was performed and the p-value derived from the above two tables (Table 1 
and Table 2) was 0.88 (>0.05), which indicates that there is no significant statistical difference for 
these  two  data  divisions  for  QSAR  analysis.  Our  result  has  shown  that  clustering  data  before 
calculating the diverse set does not produce a significant influence on the QSAR models. This result 
was explained by analysis of the detailed algorithm in calculating the diverse set as follows: The 
Diverse Subset method used in MOE [19] ranks entries based on the whole dataset diversity, that is, 
the calculation of Diverse Subset itself is a global diversity comparison procedure. For the Cluster plus 
Diverse  Set  method,  although  an  extra  preprocess  of  clustering  data  exists,  Diverse  Subset  still 
happens  within  every  sub-cluster  and  the  main  difference,  compared  with  the  former,  is  that 
calculating diverse subset becomes a local procedure based on each clustering. It can be seen that 
essentially the two division methods have little influence on the final distribution of training data and 
testing data. Thus, as expected in our results, no significant differences for the results of these two 
division methods exist. 
2.3. Comparison of PLS and SVR for QSAR Data Regression 
When building a QSAR model, linear regression methods are normally preferred to the advanced 
non-linear  methods,  since  the  linear  models  are  easier  to  use  for  a  physical  explanation  of  the 
prediction results. The most classical liner model in QSAR is PLS, which have been widely used in 
popular computer-aided drug design software [19–21]. In our study, PLS (MOE-PLS) was first chosen 
to derive our QSAR models. However, as indicated in Tables 1 and 2, this linear model failed to 
achieve satisfactory results in QSAR study. The correlation coefficients from self-fitting testing and 
cross validation testing are all less than 0.65. 
Since advanced machine learning methods such as ANN [22], Bayesian inference [23], Random 
Forest [24] and SVM [25] have been successfully applied in QSAR study [26–36], our QSAR models 
were rebuilt using the SVR method, which is a derived regression model with powerful fitting ability 
as well as excellent prediction accuracy [36–39]. In anticipating results, this method behaved well in 
the self-fitting testing of our training data (R2 is nearly 0.9) as well as in the cross-validation testing. 
Nevertheless, this method still performed badly in the independent test data, which indicates that such 
machine learning methods may not be generalized enough in the cyclopamine data. This is probably 
due to the fact that a substantial diversity exists in our dataset. Among the 93 data, four different 
scaffolds were found (Figure 1). In addition, there were still six molecules that did not match any of 
the scaffolds (Figure 2). Int. J. Mol. Sci. 2011, 12                       
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Figure 1. Four scaffolds found in our experimental data. 
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Figure 2. Six molecules that did not match any of the scaffolds, as mentioned above. 
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2.4. Comparison of Binary Bayesian Inference and SVM for QSAR Data Classification 
When  the  qualities  of  the  data  or  the  underlying  mechanism  are  not  suitable  for  regression 
modeling, the binary classification was applied on the data to uncover their probabilities to be active or 
inactive. MOE has offered a binary filter to filtering the numerical data. Any properties which can be 
represented in  a binary (yes/no)  way (like active/inactive,  toxic/non-toxic,  drug-like/non-drug-like, 
permeable/non-permeable, etc.) could be mapped onto such a filter. Thus, the binary classification 
model was used to rebuild the QSAR models to further reveal their intrinsic characteristics. MOE’s 
binary filters (yes/no) are based on the Bayesian inference technique as mentioned in Material and 
Methods. Continuous activity data (non-binary) can be transferred to binary values with a specific 
threshold criterion. In our study the IC50 of the drug compound is used as a cut-off.  
As shown in Table 1 and Table 2, the binary model behaved well on both training data and testing 
data sets. The overall prediction accuracy is improved to nearly 0.8 against NCI-H446 cell line. (Some Int. J. Mol. Sci. 2011, 12                       
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were up to 0.906). This result has indicated that the binary QSAR classification model is more suitable 
to guide the direction of designing novel inhibitors of Hedgehog signal pathway. 
The SVM classification was also applied to further validate the efficiency of binary classification 
models compared with regression models. The results shown in Table 1 and Table 2 reconfirmed that 
for our data the binary classification model is probably more suitable for QSAR analysis. 
2.5. Cell Line Analysis 
Four  different  cell  lines  (NCI-H446,  NCI-H157,  SW1990  and  BxPC-3)  were  used  to  test  the 
cytotoxicity of the 93 compounds. However, only the data of NCI-H446 can produce a reasonable 
model  by  QSAR  analysis;  the  prediction  accuracy  of  the  models  against  all  the  other  cell  lines  
is about 0.6.  
Why do some specific cell lines not fit well to our QSAR analysis? We speculate that the most 
likely reason is the non-specific cytotoxicity effect of these compounds to the other three cell lines. For 
example, HCI-H157 and BxPC-3 do not express the Gli and Smoothened protein, respectively [40,41]. 
That means that the cytotoxicity effect of these compounds may not directly result from the inhibition 
of hedgehog signaling. In addition, although sustained hedgehog signaling activity can be detected in 
SW1990  cells  [41],  it  is  very  likely  that  cell  lines  grown  in  vitro  may  lose  their  dependence  on 
hedgehog signaling for survival [42]. For example, the IC50 of positive compound (cyclopamine) is 
9.13 μg/mL for NCI-H446, 38.11 μg/mL for BxPC-3, 61.05 μg/mL for SW1990 and 58.33 μg/mL for 
NCI-H157.  That  is to say, firstly, HCI-H466  cells  were most sensitive to the  hedgehog signaling 
inhibitor.  In  addition,  the  SW1990  possibly  mutated  and  lost  the  hedgehog  signaling  in  our 
experiment.  In  summary,  the  non-specific  effects  may  result  in  the  variance  of  the  data  of  the 
cytotoxicity and finally affect the QSAR analysis.  
2.6. Structure Activity Report 
In our study, SAReport was applied to present a direct instruction on how to modify the structure of 
a compound and make it a better inhibitor of hedgehog signal pathway. All the structure modifications 
are listed in the supplementary material. Here the top three structures were selected with their activity 
improvements according to different modification mechanisms. 
The first important finding is that through such SAReport we validated our former finding that only 
the  data  to  cell  line  NCI-H446  can  obtain  a  reasonable  QSAR  modeling  result  (indicated  in  
Figure 3). Secondly, our SAReport has shown that demethylation, methylation and hydroxylation at a 
specific position of the inhibitor scaffold may highly improve their activity. As indicated in Figure 3, 
demethylation at position 8, methylation at position 7 and hydroxylation at position 11 provided three 
possible ways to improve the inhibitor’s activity. In addition, the SAReport shows that demethylation 
seems to be the most efficient approach to improve activity among others. This conclusion provides 
the first proven set of efficient inhibitor structure modification methods in order to improve their 
activities. All these results will definitely shed new light on the future work of inhibitor synthesis.  Int. J. Mol. Sci. 2011, 12                       
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Figure 3. SAReport of Hedgehog inhibitors. 
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(a) Removal of methyl group connected to C8 could increase potency of compounds. 
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(b)  Addition  of  methyl  group  connected  to  C7  on  B  ring  could  increase  potency  
of compounds. Int. J. Mol. Sci. 2011, 12                       
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Figure 3. Cont. 
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(c) Addition of hydroxyl group connected to C11 on the C ring could increase potency  
of compounds. 
3. Material and Methods 
A  comprehensive  computational  workflow  was  designed  to  perform  QSAR  analysis  on  the 
inhibitors of Hedgehog signaling. This workflow is outlined in Figure 4. Details are listed below. 
Figure 4. General computational workflow used in our study. 
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Our analysis started by using two different descriptors, i.e., general descriptors and drug-like index 
to describe the 93 cyclopamine derivates. In order to construct the training set and testing set for 
statistical modeling, two kinds of data division method were tried, i.e., Diverse Subset and Clustering Int. J. Mol. Sci. 2011, 12                       
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Diverse Subset for data generations. Then, based on the training data we obtained, different statistical 
modeling  approaches  including  PLS,  SVR,  Naive  Bayesian  classification  and SVM  classification 
were applied to evaluate their abilities for QSAR modeling. It should be noted that the former two 
methods are used to perform regression on the QSAR data and the other two methods are focusing on 
data classification. These approaches were applied in the testing data for further validation and derive 
useful clues for the designing of efficient inhibitors of Hedgehog signal pathway. Finally a SAReport 
of QSAR modeling of such inhibitors was presented for the first time. 
3.1. Dataset and Data Division Methods 
93 cyclopamine derivatives together with their activities against four different cell lines (BxPC-3, 
NCI-H446, SW1990 and NCI-H157) were tested and are listed in the supplementary material.  
Two  different  approaches  were  applied  to  divide  these  experimental  data  into  training  set  and 
testing set for our following statistical modeling. Details followed. 
3.1.1. Diverse Subset 
Briefly, the Diverse Subset method presented in MOE ranks compound entries based on diversity. 
In the procedure of data division, the first entry of the original dataset is taken as a reference and will 
always be viewed as part of a diverse subset. Then the most “distant” compound data is assigned #2, 
and then the most distant compound to these two is assigned #3 and so on until the required number of 
diverse compounds is identified or the whole dataset is ranked in diversity order. To determine which 
unranked entry is farthest from all already-ranked entries, the distance between each unranked entry 
and each ranked entry is calculated. For each unranked entry, the minimum of its distances to each 
ranked  entry  is  found.  The  entry  with  the  largest  such  “minimum  distance”  is  deemed  to  be  the 
farthest. Then such ranked dataset is divided into two parts as a training dataset (65% of the original 
set) and testing dataset (35% of the original set). 
3.1.2. Cluster plus Diverse Subset 
Compared with the above method, a clustering process is used here before Diverse Subset. Then the 
Diverse Subset is performed on each cluster to rank them respectively. Finally the training dataset and 
testing  dataset  are  generated  by  summarizing  the  sub-training  dataset  (65%  of  every  sub-cluster 
dataset) and testing dataset (35% of the every sub-cluster dataset) from every sub-cluster, respectively. 
It should be noted that MOE can cluster the whole data based on the descriptors or fingerprints. For 
time purposes, the descriptor-based clustering in MOE was used in our study because it is a simple 3N 
algorithm whereas fingerprint-based clustering uses the N2 Jarvis-Patrick algorithm.  
3.2. Structural Descriptors 
There are lots of descriptors to describe a chemical compound, including constitutional descriptors, 
physiochemical  property  descriptors,  electronic  descriptors,  topological  indices,  geometrical 
descriptors,  and  quantum  chemistry  descriptors,  etc.  However,  no  set  of  descriptors  is  capable  of 
performing spectacularly better than the others. Thus, to build our QSAR model, the widely applicable Int. J. Mol. Sci. 2011, 12                       
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set of descriptors, i.e., the general descriptors was selected. Also, DLI descriptors was adopted for a 
complementary comparison. 
General  descriptors  include  atomic  contributions  to  van  der  Waals  surface  area,  log  P 
(octanol/water), molar refractivity and partial charge. These descriptors are applied to the construction 
of QSAR models for boiling point, vapor pressure, free energy of salvation in water, solubility in 
water, thrombin/trypsin/factor Xa activity, blood-brain barrier permeability and compound classification. 
The  wide  applications  of  these  descriptors  have  suggested  their  important  usage  in  the  QSAR 
modeling, combinatorial library design and molecular diversity work. 
On the other hand, DLI descriptors acts as an approach to measure drug-like compounds, as first 
presented  by  Xu  et  al.  Then  it  was  used  and  modified  as  a  set  of  descriptors  by  MOE.  These 
descriptors  characterized  the  hierarchy  of  drug  structures  in  terms  of  rings,  links,  and 
molecular frameworks. 
Although these two sets of descriptors are both computable from connection table information, they 
partly  complement  each  other.  Normally,  general  descriptors  have  a  preference  for  physical 
prosperities of compounds, while DLI descriptors favor simple topological indices of compounds. 
3.3. Statistic Modeling 
In  our  computational  framework,  various  statistical  models  were  incorporated  to  evaluate  their 
performance in QSAR analysis of inhibitors of Hedgehog signal pathway, and we wanted to find the 
most suitable statistical analysis method for the QSAR modeling of such data. Detailed descriptions of 
each statistical method are listed below. 
3.3.1. PLS Method 
The  PLS  QSAR  method  [43,44]  was  widely  employed  in  the  study  of  QSAR  modeling  by  the 
QuaSAR-Model module of MOE 2008. This is arguably the most traditional and least sophisticated 
QSAR approach among those explored in this study. It was explored here to test if it could build reliable 
models for underlying data sets using the simplest approach. In our study, we applied the PLS method 
presented in MOE and the number of components was set to no limit on the degree of the fit. The 
maximum  condition  number  of  the  principal  component  transform  of  the  correlation  matrix  S,  the 
condition limit, was set at 1.0 ×  10
6 which is a very high setting. The leave-one-out cross validation 
(LOO-CV)  scheme  was  used  to  validate  the  models  and  the  correlation  coefficient  (Q2)  and  
root-mean-square error (RMSE) were reported. 
3.3.2. SVR 
SVR was used here to compare with PLS regression, which has proven to be a powerful regression 
technique in many applications. SVR is the regression version derived from SVM which was proposed in 
1996 by Vladimir Vapnik et al. [45]. This regression method depends only on a subset of the training 
data and the cost function for building the model ignores any training data close to the model prediction 
(within a threshold ε). Intrinsically, SVR maintains all the main features that characterize the maximal 
margin algorithm and a non-linear function is learned by a linear learning machine in a kernel-induced Int. J. Mol. Sci. 2011, 12                       
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feature space while the capacity of the system is controlled by a parameter that does not depend on the 
dimensionality  of  the  space.  In  summary,  the  basic  idea  of  SVR  is  to  map  the  data  into  a  
high-dimensional feature space via nonlinear mapping, and perform linear regression in this space. 
3.3.3. Binary Bayesian Inference 
The binary bayesian QSAR method was employed by using the QuaSAR-Model module of MOE 
2008.  In  this  modeling,  the  numerical  values  of  inhibitor  activity  were  transferred  to  binary 
classification labels, thus greatly reduced the noise of the data. That is, the binary model is used to 
predict a probability of a given compound to be either active or inactive rather than their numerical 
values. Since no quantitative estimation of the actual activity is derived, the compounds are referred to 
as “active” if its predicted probability of being active is more than 0.5. 
In binary Bayesian inference for each compound, the following steps were applied to predict their 
probability of being active [46]: 
•  Estimates two distributions: one for the active compounds and one for the inactive ones in  
the  training  set.  The  separation  of  active  and  inactive  sets  is  manually  defined  by  a  
Binary Threshold.  
•  Counts the frequency of occurrence of a particular descriptor value in active and inactive cases.  
•  Accumulates a histogram of the observed sample values over the classes. The distribution is 
convoluted  with  a  Gaussian  (  =  0.25,  the  smoothing  width)  to  avoid  sensitivity  to  
bin boundaries. 
•  A histogram of property distributions is derived for each descriptor for “active” and “inactive” 
(yes/no) sets. Those descriptors which differentiate the two sets will have a high impact in the 
model, those which do not, will drop out.  
3.3.4. SVM Classification 
Compared with binary Bayesian classification, the SVM classification was also applied for our 
QSAR data. SVM works by mapping the training data into a feature space with the aid of a so-called 
kernel function and then separating the data using a large margin hyperplane. Intuitively, the kernel 
computes a similarity between two given examples. Most commonly used kernel functions are radial 
basis function kernels and was used in our experiments. SVM classifiers are generated by a two-step 
procedure: First, the sample data vectors are mapped (“projected”) to a very high-dimensional space. 
The dimension of this space is significantly larger than the dimension of the original data space. Then, 
the algorithm finds a hyperplane in this space with the largest margin separating classes of data. It was 
shown that classification accuracy usually depends only weakly on the specific projection, provided 
that the target space is sufficiently high dimensional. Sometimes it is not possible to find the separating 
hyperplane even in a very high-dimensional space. In this case a tradeoff is introduced between the 
size of the separating margin and penalties for every vector which is within the margin. Int. J. Mol. Sci. 2011, 12                       
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3.4. SAReport 
SAReport [47] is an important tool for the visualization and analysis of project SAR data introduced 
by  MOE  recently.  SAReport  contains  sophisticated  analysis  methods  to  help  scientists  identify 
important groups and make more effective choices for synthesis. 
Briefly, the Suggestions table in SAReport consists of a list of hypothetical molecules, constructed 
from  available  pieces,  which  are  predicted  to  have  a  high  probability  of  activity.  The  pool  of 
hypothetical  molecules  is  prepared  by  enumerating  all  of  the  input  molecules,  and  performing 
 single-point mutations at each of the substitute positions, with each of the R-groups that have been 
observed  in  the  equivalent  position  for  some  other  molecule  in  the  dataset.  The  unique  list  of 
chimerical molecules is then rated according to an estimate of probability, scaled and balanced to 
match the distribution of activities found in the input set. The scores are scaled in such a way that a 
value of 0 indicates that the hypothetical molecule is as likely to be active as an average molecule in 
the input set, while positive values are more likely. The chimerical molecules are ranked by their 
probability of activity, multiplied by a weighting factor, which is a measure of cumulative similarity to 
other molecules in the database. A higher weighting implies that a larger statistical base is available to 
make the prediction. The most promising candidates are listed first. The molecule from which the 
candidate was mutated is shown, along with its property information. The new structure is shown to 
the right, along with the prediction. The percentage value is the increased probability of activity, and 
the number in brackets is the weighting.  
4. Conclusions 
In this study, different descriptors, different data dividing approaches as well as different statistic 
methods  are  used  to  build  QSAR  models  for  inhibitors  of  Hedgehog  signal  pathway  on  
93  cyclopamine  derivatives  together  with  their  activities  against  four  different  cell  lines.  Our 
investigation  has  shown  that  NCI-466  may  serve  as  the best  cell  line  for  testing  the  activities  of 
inhibitors of Hedgehog signal pathway. Due to the lower qualities of the data, the binary classification 
method is a much better choice in building QSAR models than regression. Furthermore, for synthesis 
and medical scientists, our results indicate that demethylation, methylation and hydroxylation at a 
specific  position  may  highly  improve  the  activity  of  inhibitors  of  Hedgehog  signal  pathway. 
Demethylation is also found to be a better choice than methylation or hydroxylation for compound 
modification. Based on these conclusions, demethylation is preferred to methylation or hydroxylation 
in compound modification and such work is currently being actively pursued in our laboratory.  
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